Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price shot up 2.5% during trading on Tuesday . The company traded as high as $1.85 and last traded at $1.85. 5,212,722 shares were traded during trading, a decline of 79% from the average session volume of 25,063,506 shares. The stock had previously closed at $1.80.
Tilray Trading Up 1.4 %
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of -4.19 and a beta of 2.13. The company has a 50 day moving average of $1.82 and a 200-day moving average of $1.87.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The company had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The firm’s revenue was up 24.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.15) EPS. On average, research analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current year.
Institutional Inflows and Outflows
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- Compound Interest and Why It Matters When Investing
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- There Are Different Types of Stock To Invest In
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Are Penny Stocks a Good Fit for Your Portfolio?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.